openPR Logo
Press release

Cardiometabolic Diseases Market Size, Share, Industry Analysis, Segments And Forecast To 2033

Cardiometabolic Diseases Market

Cardiometabolic Diseases Market

The new report published by The Business Research Company, titled Cardiometabolic Diseases Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the cardiometabolic diseases market size has grown steadily in recent years. It will grow from $106.3 billion in 2023 to $110.9 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The cardiometabolic diseases market size is expected to see steady growth in the next few years. It will grow to $128.98 billion in 2028 at a compound annual growth rate (CAGR) of 3.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=11929&type=smp

Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market
A high rate of obesity is expected to propel the growth of the cardiometabolic disease market going forward. Obesity is a complex condition characterized by the excessive accumulation of body fat, leading to higher body weight. Obesity directly influences the occurrence of cardiovascular risk factors such as dyslipidemia, type 2 diabetes, hypertension, and sleep problems. For instance, in March 2022, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, over 1 billion individuals are affected by obesity globally, which included 340 million teenagers, 650 million adults, and 39 million kids each year. By 2025, the WHO predicts that 167 million adults and children are going to lose some of their health due to being overweight or obese. Therefore, the high rate of obesity is driving the growth of the cardiometabolic diseases market.

Cardiometabolic Diseases Market Embraces Advanced Solutions
The adoption of advanced technologies is a key trend gaining popularity in the cardiometabolic diseases market. Companies involved in the market for cardiometabolic diseases are working on adopting novel technologies to sustain their position in the market. For instance, in February 2023, Eko Health Inc., a US-based inventor of heart and lung disease-detecting digital health technologies, launched the Sensora cardiac disease detection platform. It includes artificial intelligence (AI) that reliably detects structural murmurs, a symptom of valvular heart disease (VHD), and care pathway analytics software that provides metrics and downstream insight into the patient journey through the healthcare system. This digital stethoscope is used to capture and analyze electrical impulses and heartbeats.

The cardiometabolic diseases market covered in this report is segmented -

1) By Type: Chronic/Congestive Heart Failure, Hypertension, Type 2 Diabetes, Obesity
2) By Treatment: ACE inhibitors, Diuretics, Glucophage, Liposuction, Other Treatments
3) By Dosage: Tablet, Injection
4) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
5) By End-Users: Clinic, Hospital, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=11929&type=discount

Major companies operating in the cardiometabolic diseases market report are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Kowa Company Ltd., Thermo Fisher Scientific, Abbott Laboratories, Takeda Pharmaceutical Company, Eli Lilly and Company, Novo Nordisk A/S, Siemens Healthineers, Boehringer Ingelheim International GmbH, Becton, Dickinson and Company, Stryker Corporation, AstraZeneca Plc, Viatris Inc., Biocrates Life Sciences AG, Boston Scientific, Astellas Pharma Inc., Terumo Corporation, Agilent Technologies, Edwards Lifesciences, Bruker Corporation, Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Cardax Inc.

Contents of the report:
1. Executive Summary
2. Cardiometabolic Diseases Market Report Structure
3. Cardiometabolic Diseases Market Trends And Strategies
4. Cardiometabolic Diseases Market - Macro Economic Scenario
5. Cardiometabolic Diseases Market Size And Growth
…..
27. Cardiometabolic Diseases Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/cardiometabolic-diseases-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiometabolic Diseases Market Size, Share, Industry Analysis, Segments And Forecast To 2033 here

News-ID: 3589934 • Views:

More Releases from The Business Research Company

Future Perspective: Key Factors Influencing the Intelligent Road System Market Until 2029
Future Perspective: Key Factors Influencing the Intelligent Road System Market U …
The intelligent road system market is rapidly advancing as technology and infrastructure evolve to meet the demands of modern transportation. With the rise of autonomous vehicles and smart city initiatives, this sector is set to experience significant growth in the coming years. Here, we explore the market's size, leading players, key trends, and segmentation to provide a comprehensive overview of the intelligent road system landscape. Strong Growth Outlook for the Intelligent
Segment Analysis and Major Growth Areas in the Consumer Telematics Market
Segment Analysis and Major Growth Areas in the Consumer Telematics Market
The consumer telematics market is on the brink of remarkable expansion, driven by increasing demand for vehicle monitoring and safety solutions. Advances in technology combined with growing smartphone usage and affordable data plans are setting the stage for significant market growth. Let's explore the current market size, key players, emerging trends, and detailed segment insights shaping this industry's future. Consumer Telematics Market Size and Growth Projections The consumer telematics market
Worldwide Trends Overview: The Rapid Evolution of the Vehicle Diagnostics Market
Worldwide Trends Overview: The Rapid Evolution of the Vehicle Diagnostics Market
The vehicle diagnostics sector is gearing up for significant expansion, driven by rapid technological advancements and evolving automotive needs. As vehicles become increasingly complex and connected, diagnostic solutions are evolving to offer more precise, efficient, and predictive capabilities. Let's explore the current market size, key players, emerging trends, and segmentation details that shape the future of this dynamic industry. Projected Market Growth and Size of the Vehicle Diagnostics Market The
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Electric Vehicle Battery Swapping Market
In-Depth Examination of Segments, Industry Trends, and Key Competitors in the El …
The electric vehicle battery swapping market is on the brink of remarkable expansion in the coming years, driven by innovative technologies and growing environmental awareness. As the demand for zero-emission vehicles intensifies, this market is set to transform how electric vehicle users recharge their batteries, promising faster, more convenient solutions. Below is a detailed look at the market's future size, key players, emerging trends, and important segments shaping its trajectory. Strong

All 5 Releases


More Releases for Cardiometabolic

Cardiometabolic Disease Market to Reach $60.81B by 2035
Cardiometabolic Disease Market Poised for Steady Growth Amid Rising Global Health Concerns Tackling the Global Cardiometabolic Health Crisis Cardiometabolic diseases-including obesity, type 2 diabetes, hypertension, and chronic heart failure-represent a major global health challenge, contributing to morbidity, mortality, and escalating healthcare costs. These interlinked conditions share common risk factors such as sedentary lifestyle, unhealthy diets, and aging populations, creating a pressing need for effective preventive and therapeutic interventions. The global cardiometabolic disease market
Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market: Powering Inn …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Cardiometabolic Diseases Market Through 2025? The valuation of the cardiometabolic diseases sector has experienced consistent expansion over the last several years, projected to climb from $111.64 billion in 2024 up to $115.27 billion the following year, reflecting a 3.3% compound annual growth
Charting a New Era in Cardiometabolic Care: The Global Cardiometabolic Drug Mark …
In an era defined by rising rates of obesity, diabetes, and cardiovascular disease, the global cardiometabolic drug market has emerged as a cornerstone of modern healthcare. Spanning therapies for type 2 diabetes, dyslipidemia, hypertension, and related metabolic disorders, this market is not only addressing some of the world's most pressing health challenges but is also redefining standards of patient care through precision targeted medicines, innovative delivery systems, and breakthrough combination
Rising Obesity Rates Fuel Growth In Cardiometabolic Disease Market: Key Factor D …
The Cardiometabolic Diseases Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Cardiometabolic Diseases Market Size During the Forecast Period? The Cardiometabolic Diseases Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This
Cardiometabolic Diseases Market Embraces Advanced Solutions Trend: A Crucial Inf …
What industry-specific factors are fueling the growth of the cardiometabolic diseases market? The cardiometabolic disease market is projected to grow due to the anticipated rise in obesity rates. Being a multifaceted disorder, obesity is identified by an overly excessive accumulation of fat in the body, resulting in increased body weight. This directly impacts the occurrence of cardiovascular risk determinants such as dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. For example,
Cardiometabolic Diseases Market Analysis & Opportunities 2024-2033
"The Business Research Company recently released a comprehensive report on the Global Cardiometabolic Diseases Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample